Citations

Showing 10 of 108152 citations.

Impaired central hemodynamics in chronic obstructive pulmonary disease during submaximal exercise
Smith, Joshua R. , Johnson, Bruce D. , Olson, Thomas P. , Smith, Joshua R

Mayo Clinic

Journal of Applied Physiology | July 11, 2019 | Volume: 127 | Issue: 3 | Pages: 691-697

10.1152/japplphysiol.00877.2018 | PMID 31295068 Get It

It is unknown whether central hemodynamics are impaired during exercise in chronic obstructive pulmonary disease (COPD) patients. We hypothesized that, at a similar absolute V̇o2 during exercise, COPD patients would have a lower stroke volume and cardiac output compared with healthy controls. Furthermore, we hypothesized that greater static hyperinflation [ratio of inspiratory capacity to total lung capacity (IC/TLC)] and expiratory intrathoracic pressure would be significantly related to the lower cardiac output and stroke volume responses in COPD patients. Clinically stable COPD ( n = 13; FEV1/FVC: 52 ± 13%) and controls ( n = 10) performed constant workload submaximal exercise at an absolute V̇o2 of ~1.3 L/min. During exercise, inspiratory capacity maneuvers were performed to determine operating lung volumes and cardiac output (via open-circuit acetylene rebreathe technique) and esophageal pressure were measured. At similar absolute V̇o2 during exercise ( P = 0.81), COPD had lower cardiac output than controls (COPD: 11.0 ± 1.6 vs. control: 12.2 ± 1.2 L/min, P = 0.03) due to a lower stroke volume (COPD: 107 ± 13 vs. control: 119 ± 19 mL, P = 0.04). The heart rate response during exercise was not different between groups ( P = 0.66). FEV1 (%predicted) and IC/TLC were positively related to stroke volume ( r = 0.68, P = 0.01 and r = 0.77, P < 0.01). Last, esophageal pressure-time integral during inspiration was positively related to cardiac output ( r = 0.56, P = 0.047). These data demonstrate that COPD patients have attenuated cardiac output and stroke volume responses during exercise compared with control. Furthermore, these data suggest that the COPD patients with the most severe hyperinflation and more negative inspiratory intrathoracic pressures have the most impaired central hemodynamic responses. NEW & NOTEWORTHY Chronic obstructive pulmonary disease leads to cardiac structural changes and pulmonary derangements that impact the integrative response to exercise. However, it is unknown whether these pathophysiological alterations influence the cardiac response during exercise. Herein, we demonstrate that COPD patients exhibit impaired central hemodynamics during exercise that are worsened with greater hyperinflation.
Diversion Principle Reduces Skin Flora Contamination Rates in a Community Hospital
Syed, Sadia, Costas, Chris, Atkinson, Janis, Liss, David T, Costas, Chris O, Atkinson, Janis M, Liss, David T.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | July 11, 2019 | Volume: 144 | Issue: 2 | Pages: 215-220

10.5858/arpa.2018-0524-oa | PMID 31295014 Get It

Context.— Blood culture contamination is a common problem faced by medical centers and leads to significant cost. A possible method to reduce contamination is to discard the initial aliquot of blood, which contains skin and bacteria. Objective.— To determine whether the rate of contaminant blood cultures could be reduced by changing the order of draw to divert the first 7 mL to a gold- or green-top tube. Design.— A preintervention and postintervention study was conducted. During the 18-month intervention phase (September 2015–February 2017), all nurses in the emergency department and inpatient floor phlebotomists collected blood cultures by drawing the first 7 mL of blood into a gold- or green-top tube followed by drawing blood for blood culture bottles. The 18 months immediately preceding the study period (February 2014–July 2015) were used for comparison. Results.— There was an overall statistically significant decrease in contamination rate from 2.46% in the prediversion protocol group to 1.70% in the postdiversion protocol group (P &lt; .001). Emergency department drawn cultures and inpatient cultures showed significant decrease in contamination rates between the preprotocol and postprotocol groups, 2.92% versus 1.95% (P &lt; .001) for emergency department, and 1.82% versus 1.31% (P = .03) for inpatient. We noted less month-to-month variation during the study period compared with the preintervention period. Conclusions.— By using this simple diversion method, we were able to improve blood culture contamination rates for our emergency department and inpatients while incurring no added cost to the procedure.
Higher dietary protein intake preserves lean body mass, lowers liver lipid deposition, and maintains metabolic control in participants with long‐chain fatty acid oxidation disorders
Gillingham, Melanie B. , Elizondo, Gabriela , Behrend, Annie, Matern, Dietrich , Schoeller, Dale A. , Purnell, Jonathan Q. , Harding, Cary O. , Gillingham, Melanie B

Mayo Clinic

Journal of Inherited Metabolic Disease | July 11, 2019 | Volume: 42 | Issue: 5 | Pages: 857-869

10.1002/jimd.12155 | PMID 31295363 Get It

Abstract Medical nutrition therapy for long‐chain fatty acid oxidation disorders (LC‐FAODs) currently emphasizes fasting avoidance, restricted dietary long‐chain fatty acid intake, supplementation with medium chain triglycerides, and increased carbohydrate intake. We hypothesize that increasing dietary protein intake relative to carbohydrate intake would preserve metabolic control yet induce physical benefits including reduced hepatic lipogenesis. Therefore, we compared two dietary approaches with similar fat intake but different carbohydrate to protein ratios in participants diagnosed with LC‐FAODs. Thirteen participants were enrolled and randomized into either a high‐protein (PRO) or a high‐carbohydrate (CHO) diet for 4 months. Baseline and 4‐month assessments included body composition, ectopic lipid deposition, and resting energy expenditure. End of study assessments also included total energy expenditure, metabolic responses to oral feedings, and whole‐body fatty acid oxidation capacity. At the end of the dietary intervention, both groups had similar energy expenditure, fat and glucose oxidation rates, and glucolipid responses to mixed meal and oral glucose loads. Neither dietary group experienced worsening symptoms related to their LC‐FAOD. Compared to the CHO group, the PRO group exhibited increased blood levels of short‐chain acylcarnitines, reduced intrahepatic lipid content, and maintained lean body mass while the CHO group lost lean mass. In patients with LC‐FAODs, increasing protein intake maintained metabolic control, reduced liver fat without risk of metabolic decompensation, and helped preserve lean body mass. We propose that a modest increase in dietary protein along with fasting avoidance and fat restriction may improve body composition and energy expenditure in patients with LC‐FAODs.
Assessment of complement interference in anti-Müllerian hormone immunoassays
Turner, Katherine A., Larson, Bethany J., Kreofsky, Nina C., Bornhorst, Joshua A. , Bornhorst, Joshua , Willrich, Maria Alice V. , Algeciras‐Schimnich, Alicia

Mayo Clinic

Clinical Chemistry and Laboratory Medicine (CCLM) | July 11, 2019 | Volume: 58 | Issue: 1 | Pages: e8-e10

10.1515/cclm-2019-0496 | PMID 31815379 Get It

A Prospective, Randomized, Blinded Trial Comparing Digital Simulation to Textbook for Cleft Surgery Education
Rajesh, Aashish , Vyas, Krishna S. , Asaad, Malke

Mayo Clinic

Plastic & Reconstructive Surgery | July 11, 2019 | Volume: 144 | Issue: 4 | Pages: 716e-717e

10.1097/prs.0000000000006053 | PMID 31568338 Get It

The Value of Business Training in the Quest for Sustainable Health Care Delivery in Plastic Surgery
Patrinely, James R. , Drolet, Brian C. , Forte, Antonio J. , Forte, Antonio Jorge , Perdikis, Galen

Mayo Clinic

Annals of Plastic Surgery | July 11, 2019 | Volume: 83 | Issue: 2 | Pages: 121-122

10.1097/sap.0000000000002010 | PMID 31295168 Get It

Differentiating the General Vestibular Schwannoma Patient Population, Tertiary Referral Center Cohorts, and the Acoustic Neuroma Association Survey Respondents: A Response to the Benefits and Drawbacks of Survey-Based Studies
Marinelli, John P. , Prummer, Christoph M., Link, Michael J. , Carlson, Matthew L.

Mayo Clinic

Otology & Neurotology | July 11, 2019 | Volume: 40 | Issue: 7 | Pages: 980-982

10.1097/mao.0000000000002308 | PMID 31295210 Get It

Detection of Inflammatory Aortopathies Using Multimodality Imaging
Bois, John P. , Anand, Vidhu , Anavekar, Nandan S.

Mayo Clinic

Circulation: Cardiovascular Imaging | July 11, 2019 | Volume: 12 | Issue: 7 | Pages: No page available

10.1161/circimaging.118.008471 | PMID 31291781 Get It

Diagnosis of the inflammatory aortopathies and importantly, their distinction in the later stages of disease from genetically mediated or acquired (degenerative) aortopathy remains a challenging clinical problem. Historically, the diagnosis of inflammatory aortopathy has required tissue sampling and pathological assessment. Although histological diagnosis remains an important diagnostic criterion, the ability to obtain sufficient tissue samples is problematic and requires invasive approaches that pose important risk. Continuing refinement in the capabilities of multimodality imaging, including ultrasound, computed tomography, magnetic resonance imaging, and positron emission tomography provides important insights into the broad spectrum of disease which comprise the inflammatory aortopathies. This review examines the current and emerging role of multimodality imaging in the evaluation of aortitis.
Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia
Giacopelli, Brian , Zhao, Qiuhong , Ruppert, Amy S. , Agyeman, Akwasi, Wu, Yue-Zhong, Gerber, Madelyn M., Rabe, Kari G. , Lu, Junyan , Rogers, Kerry A. , Brown, Jennifer R. , Rai, Kanti R., Keating, Michael J. , Rassenti, Laura Z., Shanafelt, Tait D. , Abruzzo, Lynne V. , Coombes, Kevin R. , Woyach, Jennifer A. , Byrd, John C. , Oakes, Christopher C. , Byrd, John C. , Chaffee, Kari G. , Lu, Junyan , Rogers, Kerry A , Kay, Neil E , Coombes, Kevin R , Shanafelt, Tait D , Weigel, Christoph , Wu, Yue-Zhong, Larson, Melissa C. , Blachly, James S. , Wierda, William G. , Rai, Kanti R., Kipps, Thomas J. , Zenz, Thorsten , Kay, Neil E. , Byrd, John C

Mayo Clinic

Blood | July 11, 2019 | Volume: 134 | Issue: 8 | Pages: 688-698

10.1182/blood.2019000490 | PMID 31292113 Get It

AbstractAlterations in global DNA methylation patterns are a major hallmark of cancer and represent attractive biomarkers for personalized risk stratification. Chronic lymphocytic leukemia (CLL) risk stratification studies typically focus on time to first treatment (TTFT), time to progression (TTP) after treatment, and overall survival (OS). Whereas TTFT risk stratification remains similar over time, TTP and OS have changed dramatically with the introduction of targeted therapies, such as the Bruton tyrosine kinase inhibitor ibrutinib. We have shown that genome-wide DNA methylation patterns in CLL are strongly associated with phenotypic differentiation and patient outcomes. Here, we developed a novel assay, termed methylation-iPLEX (Me-iPLEX), for high-throughput quantification of targeted panels of single cytosine guanine dinucleotides from multiple independent loci. Me-iPLEX was used to classify CLL samples into 1 of 3 known epigenetic subtypes (epitypes). We examined the impact of epitype in 1286 CLL patients from 4 independent cohorts representing a comprehensive view of CLL disease course and therapies. We found that epitype significantly predicted TTFT and OS among newly diagnosed CLL patients. Additionally, epitype predicted TTP and OS with 2 common CLL therapies: chemoimmunotherapy and ibrutinib. Epitype retained significance after stratifying by biologically related biomarkers, immunoglobulin heavy chain mutational status, and ZAP70 expression, as well as other common prognostic markers. Furthermore, among several biological traits enriched between epitypes, we found highly biased immunogenetic features, including IGLV3-21 usage in the poorly characterized intermediate-programmed CLL epitype. In summary, Me-iPLEX is an elegant method to assess epigenetic signatures, including robust classification of CLL epitypes that independently stratify patient risk at diagnosis and time of treatment.
Cavernous Sinus Thrombosis Secondary to Sphenoid Sinus Fungal Ball
Dowling, Eric M. , Modzeski, Mara C., Dowling, Eric , Modzeski, Mara, Choby, Garret

Mayo Clinic

Ear, Nose & Throat Journal | July 11, 2019 | Volume: 98 | Issue: 9 | Pages: 540-542

10.1177/0145561319862220 | PMID 31291783 Get It